Tourmaline Bio, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TRML research report →
About the company
Tourmaline Bio, Inc. is a clinical-stage biotechnology firm committed to advancing therapies for individuals suffering from debilitating immune disorders. The company's development pipeline focuses on conditions such as Atherosclerotic Cardiovascular Disease (ASCVD) and Thyroid Eye Disease (TED).
- CEO
- Sandeep C. Kulkarni
- IPO
- 2021
- Employees
- 74
- HQ
- New York City, NY, US
Price Chart
- Market Cap
- $1.23B
- P/E
- -26.80
- P/S
- 0.00
- P/B
- 4.77
- EV/EBITDA
- -24.55
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -17.09%
- ROIC
- -20.13%
- Revenue
- $0 · 0.00%
- Net Income
- $-73,210,000 · -73.80%
- EPS
- $-2.89 · 67.42%
- Op Income
- $-89,732,000
- FCF YoY
- -174.63%
- 52W High
- $48.27
- 52W Low
- $11.56
- 50D MA
- $40.68
- 200D MA
- $22.74
- Beta
- 1.58
- Avg Volume
- 925.78K
Get TickerSpark's AI analysis on TRML
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 28, 25 | SIEGALL CLAY B | sell | 16,800 |
| Oct 28, 25 | SIEGALL CLAY B | sell | 15,000 |
| Oct 28, 25 | SIEGALL CLAY B | sell | 20,000 |
| Oct 28, 25 | Thiara Parvinder | sell | 16,800 |
| Oct 28, 25 | Thiara Parvinder | other | 83,782 |
| Oct 28, 25 | Thiara Parvinder | sell | 10,000 |
| Oct 28, 25 | Thiara Parvinder | sell | 10,000 |
| Oct 28, 25 | Srivastava Sapna | sell | 20,000 |
| Oct 28, 25 | Srivastava Sapna | sell | 16,800 |
| Oct 28, 25 | Srivastava Sapna | sell | 10,000 |
Our TRML coverage
Recent articles, reports, and earnings notes.
No research on TRML yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TRML report →Similar companies
Peers in the same neighborhood.